Who Owns ORMP?

Oramed Pharmaceuticals Inc. — Institutional Ownership & 13F Holdings

$3.92

+0.07 (+1.95%)

Market Cap

$129.9M

Shares Outstanding

40,446,179

Institutional Holders

52

Total Inst. Value

$20.0M

% of Float Held

QoQ Holder Change

+7

Institutional data as of Q1 2025

New Positions

6

Closed Positions

9

Increased

16

Decreased

16

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BML Capital Management, LLC$6.5M3,020,748
2Murchinson Ltd.$3.7M1,751,759
3NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$3.4M1,575
4BOOTHBAY FUND MANAGEMENT, LLC$1.8M845,488
5Peapod Lane Capital LLCNew$540K252,224
6Rathbones Group PLC$507K236,803
7TWO SIGMA ADVISERS, LP$456K213,000
8BANK OF AMERICA CORP /DE/$348K163,695
9RENAISSANCE TECHNOLOGIES LLC$305K142,500
10DIMENSIONAL FUND ADVISORS LP$302K141,081

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold ORMP?

As of Q1 2025, 52 institutional investors report holding ORMP (Oramed Pharmaceuticals Inc.) in their 13F filings.

Which hedge fund owns the most ORMP?

The largest institutional holder of ORMP is BML Capital Management, LLC with $6.5M in shares.

Are institutions buying or selling ORMP?

This quarter, 6 institutions opened new positions in ORMP and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.